跳至主要内容
临床试验/CTRI/2024/03/064757
CTRI/2024/03/064757尚未招募2/3 期

Efficacy of individualized homoeopathic medicines in the management of chronic insomnia in adults: Double-blind, randomized, placebo-controlled trial

D. N. De Homoeopathic Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2024年4月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
54
试验地点
1
主要终点
Pittsburg Sleep Quality Index (PSQI)

研究概览

简要总结

Insomnia is defined by the presence of an individual’s report of difficulty with sleep. Chronic insomnia is a frequent and persistent difficulty of initiating or maintaining sleep that occurs despite adequate opportunity and circumstances for sleep and that results in general sleep dissatisfaction and some form of daytime impairment. Daytime symptoms typically include fatigue, depressed mood or irritability, general malaise and cognitive impairment. The sleep disturbances and associated with symptoms occurs at least several times per week for at least 3 months. Absence of daytime symptoms are not considered as chronic insomnia. The Diagnostic and statistical Manual of Mental Disorders, 5th edition and ICSD-3, which have similar criteria for making the diagnosis. These criteria specify that symptoms must cause clinically significant functional distress or impairment be present for at least 3 nights/week for at least 3 months and not linked to other sleep, medical or mental disorders. In homoeopathy 4 randomized controlled trials done in which compared homoeopathic medicines to placebo. All involved small number of patients and were low methodological quality. None demonstrated a statistically significant difference in outcomes between groups, although two showed a trend favouring homoeopathic medicines and 3 demonstrated significant improvement from baseline in both groups. Existing RCTs were of poor quality and were likely to have been underpower. So there is need to undertake a trial to assess whether IHMs could produce any significant effect differ than placebo in adults suffering from chronic insomnia. Primary outcome measure will be used in this trial PSQI and Secondary outcome measures will be ISI and Daily Sleep Diary with Master Chart Calculator. All the outcome measures will be assessed at baseline, every month up to 3 months of follow up. Group differences will be measured statistically. Results will be published in a scientific journal.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient suffering from Chronic insomnia [ICD 11 Code: 7A00] 2.Insomnia severity index score more than
  • 3.Age 18 to 65 years and of either sex.
  • 4.Participants having prior experience or knowledge of the treatment.
  • Example- primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.

排除标准

  • 1.presence of a significant current medical like cancer or neurological disorder such as dementia, Parkinson disease which compromises sleep.
  • 2.presence of a major psychopathology like major depressive disorder, anxiety disorders.
  • 3.Alcohol or drug abuse during the past year.
  • 4.Evidence of another sleep disorder such as sleep apnea that is apnea-hypopnea index more than 15 or periodic limb movements during sleep that is myoclonic index with arousal more than
  • 5.A score of 7 or low on Insomnia Severity Index 6.Use of psychotropic or other medications known to alter sleep (e.g. bronchodilators) and (g)use of a sleep-promoting agent (e.g. benzodiazepines).
  • 7.Uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life.
  • 9.Pregnant and puerperal women, and lactating mothers.
  • 10.Substance abuse and/or dependence.
  • 11.Self-reported immune-compromised state.
  • 12.Undergoing Homoeopathic treatment for any chronic disease within last 6 months.
  • 13.Uncontrolled hypertension, diabetes, nephritic syndrome, renal insufficiency, uncontrolled hypothyroidism, severe or active liver diseases or any other uncontrolled systemic diseases affecting quality of life or organ failure.
  • 14.Vulnerable population- unconscious, non-ambulatory, too sick for consultation, differently abled, terminally and critically ill patient, mentally unstable patients.
  • 15.Patient not providing with written informed consent voluntarily.

结局指标

主要结局

Pittsburg Sleep Quality Index (PSQI)

时间窗: At baseline, every month, 3months

次要结局

  • Insomnia Severity Index (ISI)(At baseline, every month, up to 3 months)
  • Daily Sleep Diary with Master Sleep Diary Calculator (MSD)(At baseline, every month, up to 3 months)

研究者

发起方
D. N. De Homoeopathic Medical College and Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Saima Shamim

D. N. De Homoeopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验